Current status and future developments in predicting outcomes in radiation oncology
Advancements in data-driven technologies and the inclusion of information-rich multiomics
features have significantly improved the performance of outcomes modeling in radiation …
features have significantly improved the performance of outcomes modeling in radiation …
Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes …
JF Waxer, K Wong, A Modiri, AM Charpentier… - International Journal of …, 2024 - Elsevier
Purpose Radiation-induced cerebrovascular toxicity is a well-documented sequelae that can
be both life-altering and potentially fatal. We performed a meta-analysis of the relevant …
be both life-altering and potentially fatal. We performed a meta-analysis of the relevant …
[HTML][HTML] Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate …
Background and purpose Significant dose deviations have been reported between planned
(DP) and accumulated (DA) dose in prostate radiotherapy. This study aimed to develop …
(DP) and accumulated (DA) dose in prostate radiotherapy. This study aimed to develop …
[HTML][HTML] Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose
Background and purpose Significant deviations between bladder dose planned (DP) and
dose accumulated (DA) have been reported in patients receiving radiotherapy for prostate …
dose accumulated (DA) have been reported in patients receiving radiotherapy for prostate …
Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose
Background and purpose Normal tissue complication probability (NTCP) parameters
derived from traditional 3D plans may not be ideal in defining toxicity outcomes for modern …
derived from traditional 3D plans may not be ideal in defining toxicity outcomes for modern …
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East …
C Zhang, S Chen, Y Bian, X Qian, Y Liu… - Clinical & …, 2024 - Wiley Online Library
Abstract Objectives For children with Kawasaki disease (KD) at high risk of developing
coronary artery lesions and requiring retreatment with intravenous immunoglobulin (IVIG) …
coronary artery lesions and requiring retreatment with intravenous immunoglobulin (IVIG) …
Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data
H Bai, XF Wang, YH Xu, NG Zaorsky, HH Wang… - Radiotherapy and …, 2024 - Elsevier
Background and objectives The aim of this study is to establish dosimetric constraints for the
brachial plexus at risk of developing grade≥ 2 brachial plexopathy in the context of …
brachial plexus at risk of developing grade≥ 2 brachial plexopathy in the context of …
Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses
HH Wang, Y Chen, X Liu, NG Zaorsky, K Mani… - Radiotherapy and …, 2023 - Elsevier
Background Reirradiation with stereotactic body radiotherapy (SBRT) for patients with
primary or secondary lung malignancies represents an appealing definitive approach, but its …
primary or secondary lung malignancies represents an appealing definitive approach, but its …
High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an …
CC Li, CY Chen, YH Chou, CJ Huang, HY Ku, YC Lin… - Discover Oncology, 2022 - Springer
Background The optimal radiotherapy dose for locally advanced esophageal squamous cell
carcinoma in endemic areas treated with neoadjuvant concurrent chemoradiotherapy is …
carcinoma in endemic areas treated with neoadjuvant concurrent chemoradiotherapy is …
Dose-response modeling and treatment plan assessment with a python software toolkit
A Tzikas, E Lavdas, D Kechagias, P Mavroidis - Medical Dosimetry, 2024 - Elsevier
This software assistant aims at calculating the dose-response relations of tumors and normal
tissues, or clinically assessing already determined values by other researchers. It can also …
tissues, or clinically assessing already determined values by other researchers. It can also …